Acute Myeloid Leukemia Experience at King Abdulaziz Medical City – Riyadh

In a review of 180 adult patients who were diagnosed with Acute Myeloid Leukemia at King Abdulaziz Medical City – Riyadh, Dr. Khadega Abuelgasim and her colleagues found the average survival rate at 2 years to be 45%. It was higher in younger people below the age of 40, reaching 79%, while as low as 16% for those aged above 60. The investigators also noted that older patients had a better outcome when they were given high-dose chemotherapy. The investigators concluded that these results are similar to the results of published literature by other international groups.

This research paper has been published in Leukemia Research Reports 14 (2020) 100206 (



The success of our SSBMT Webinars will not be possible without the support of the pharmaceutical industries.

The April, May and June webinars are sponsored by:

Novartis and Sanofi Genzyme

If interested, send us an email at or